https://www.selleckchem.com/pr....oducts/blasticidin-s
0-25.5]; P 0.001) was higher and left ventricular ejection fraction was lower (median [IQR] 50.0 [40.0-60.0]% vs 55.0 [45.0-60.0]%; P = 0.01) in this group. All periprocedural complications did not differ among the groups. Long-term all-cause mortality at a median follow-up of 1149 days did not differ significantly (23% vs 20%; P = 0.37). The long-term mortality in CTO-RCA group was also not significantly different. Patients with ULMCAD who have undergone LM PCI in the absence of RCA support, compared with those with ULMCA
Like
Comment
Share
